Abstract:Abstract Background The occurrence of liver metastasis in pancreatic neuroendocrine tumor (pNET) after primary site surgery significantly hampers the improvement of patient’s overall survival (OS). Therefore, it is necessary for early detection of metastatic lesions. However, the relationship between clinical variables and the liver metastasis potential remains obscure. Methods Detailed information of pNET patients received primary site surgery was retrieved from the Surveillance, Epidemiology and End Results (SEER) database between 2010 and 2019. Univariate and multivariate logistic regression analysis were recruited to generate independent risk factors of liver metastasis to construct a model presented as a nomogram using training cohort of SEER database. Moreover, a testing cohort from SEER database and a cohort of 96 patients from Second Affiliated Hospital of Zhejiang University School of Medicine were further recruited for internal and external verification respectively. The receiver operating characteristic curve, calibration curve, decision curve analysis (DCA) and clinical impact curve (CIC) were used to evaluate the accuracy, reliability and clinical application value respectively. The risk subgroups were finally generated according to the score of the nomogram. Results 2458 pNET patients were included in the present study. And 1638 of them were assigned as training cohort and 820 of them were assigned as testing cohort. Tumor size, AJCC T stage, functional status and other site metastases were considered as independent risk factors of liver metastasis via multivariate logistic regression analysis (all, p < 0.05). Our nomogram showed an excellent accuracy with the area under curve (AUC) of 0.821 in training cohort, 0.766 in testing cohort and 0.817 in validation cohort, respectively. Moreover, the calibration curve, DCA and CIC indicated a better net benefit and clinical application value in training cohort, testing cohort and validation cohort compared with single variate. Finally, pNET patients could be classified into low, medium and high risk of liver metastasis. Patients with high risk of liver metastasis showed a significant poorer OS compare to other two groups. Conclusion Tumor size can be an important predictor of liver metastasis in pNET patients. The nomogram we established could predict liver metastasis of pNET patients after surgery accurately.

Predictive Value of Preoperative Peripheral Blood Neutrophil/lymphocyte Ratio for Lymph Node Metastasis in Patients of Resectable Pancreatic Neuroendocrine Tumors: a Nomogram-Based Study.

Clinical Significance of the Preoperative Main Pancreatic Duct Dilation and Neutrophil-to-lymphocyte Ratio in Pancreatic Neuroendocrine Tumors (pnets) of the Head after Curative Resection

Preoperative Neutrophil-to-lymphocyte Ratio and Tumor-Related Factors to Predict Lymph Node Metastasis in Nonfunctioning Pancreatic Neuroendocrine Tumors.

Prognostic Significance of Preoperative Neutrophil-to-Lymphocyte Ratio in Surgically Resectable Pancreatic Neuroendocrine Tumors.

Prognostic Role of Lymphocyte-to-monocyte Ratio in Pancreatic Neuroendocrine Neoplasms

Prognostic Value of the Metastatic Lymph Node Ratio in Patients with Pancreatic Cancer.

Neutrophil-lymphocyte Ratio Predicts Survival in Pancreatic Neuroendocrine Tumors.

Preoperative Lymphocyte-to-monocyte Ratio is a Superior Systemic Inflammation Marker to Predict Relapses in Patients with Pancreatic Neuroendocrine Neoplasms Following Curative Resections

Clinical value of neutrophil-to-lymphocyte ratio in patients with non-small-cell lung cancer treated with PD-1/PD-L1 inhibitors

Predicting Liver Metastasis in Pancreatic Neuroendocrine Tumor After Surgery: A Population-Based Study

Preoperative Neutrophil-to-lymphocyte Ratio and Tumor-Related Factors to Predict Lymph Node Metastasis in Patients with Pancreatic Ductal Adenocarcinoma (PDAC)

Value of markers of systemic inflammation for the prediction of postoperative progression in patients with pancreatic neuroendocrine tumors

The Value of Preoperative Neutrophil to Lymphocyte Ratio in Indicating Lymph Node Metastasis in Patients with Resectable T2 Stage Gastric Adenocarcinoma.

Prognostic role of the neutrophil-to-lymphocyte ratio in pancreatic cancer: a meta-analysis

Validation of the pretreatment neutrophil-lymphocyte ratio as a predictor of overall survival in a cohort of patients with pancreatic ductal adenocarcinoma.

Preoperative Prediction of Lymph Node Metastasis in Nonfunctioning Pancreatic Neuroendocrine Tumors from Clinical and MRI Features: a Multicenter Study

Preoperative Prediction of Lymph Node Metastases in Nonfunctional Pancreatic Neuroendocrine Tumors Using a Combined CT Radiomics-Clinical Model

Lymph node ratio, but not the total number of examined lymph nodes or lymph node metastasis, is a predictor of overall survival for pancreatic neuroendocrine neoplasms after surgical resection.

Development and validation of nomogram to predict lymph node metastasis preoperatively in patients with pancreatic neuroendocrine tumor

The relationship between neutrophil-lymphocyte ratio and prognosis of colorectal cancer

Pretreatment Neutrophil-to-lymphocyte Ratio is Correlated with Response to Neoadjuvant Chemotherapy As an Independent Prognostic Indicator in Breast Cancer Patients: a Retrospective Study